Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Prostatic Neoplasms 1Pain, Postoperative 1Myoma 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Anesthesia 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 27Dexmedetomidine 8Radiotherapy 7Radiation 7Proton Therapy 7Mental Status and Dementia Tests 7Magnetic Resonance Imaging 7Exercise 6Surgical Procedures, Operative 5Specimen Handling 5Saline Solution 5Blood Specimen Collection 5Bevacizumab 5Remifentanil 4Radiotherapy, Intensity-Modulated 4Propofol 4alovudine 3Transcranial Magnetic Stimulation 3Temozolomide 3Resistance Training 3Methods 3Mannitol 3Diffusion Tensor Imaging 3Cognitive Training 3gadobutrol 2gadobenic acid 2Yoga 2Vitamin D 2Ultrasonography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Brain Neoplasms × Magnesium Sulfate × Clear all
NCT05743725 2023-02-24

Dexmedetomidine Versus Magnesium Sulphate in Patients Undergoing Craniotomy for Deeply Settled Intracranial Tumours

Assiut University

Phase NA Unknown
150 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡